Lipid nanoparticles (LNPs) are emerging as a breakthrough technology in modern medicine. Originally known for their role in mRNA vaccines, LNPs are now paving the way for innovative treatments far beyond infectious diseases — targeting conditions once deemed unreachable. The following message from our executive leadership emphasizes the transformative potential of LNP technology and the importance of continued research in this field.